We are live on ! Find out more
PLRX icon

Pliant Therapeutics

55 hedge funds and large institutions have $635M invested in Pliant Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 11

49% more funds holding

Funds holding: 3755 (+18)

0.14% less ownership

Funds ownership: 79.7%79.56% (-0.14%)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

28% less capital invested

Capital invested by funds: $877M → $635M (-$242M)

Holders
55
Holders Change
+18
Holders Change %
+48.65%
% of All Funds
1.11%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
29
Increased
7
Reduced
9
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CCM
26
CAAS Capital Management
New York
$566K
N
27
Nuveen
North Carolina
$523K +$577K +23,105 New
Alyeska Investment Group
28
Alyeska Investment Group
Illinois
$466K -$1.25M -50,000 -71%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$425K +$468K +18,747 New
Morgan Stanley
30
Morgan Stanley
New York
$368K +$364K +14,556 +856%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$357K +$394K +15,765 New
DCM
32
Dupont Capital Management
Delaware
$278K +$307K +12,266 New
Wells Fargo
33
Wells Fargo
California
$182K +$201K +8,042 New
GC
34
Grace Capital
Massachusetts
$160K +$27.5K +1,100 +18%
AIG
35
American International Group
New York
$141K +$156K +6,229 New
Deutsche Bank
36
Deutsche Bank
Germany
$126K +$139K +5,566 New
MIM
37
MetLife Investment Management
New Jersey
$110K +$122K +4,875 New
TRCT
38
Tower Research Capital (TRC)
New York
$100K +$111K +4,425 New
JP Morgan Chase
39
JP Morgan Chase
New York
$92K +$97K +3,883 New
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$75.8K +$83.6K +3,347 New
SO
41
STRS Ohio
Ohio
$58K +$65K +2,600 New
UBS Group
42
UBS Group
Switzerland
$57K +$62.7K +2,510 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$54K +$60K +2,400 New
GWM
44
Geneos Wealth Management
Colorado
$32K +$37.5K +1,500 New
Osaic Holdings
45
Osaic Holdings
Arizona
$27K -$15.6K -625 -35%
Legal & General Group
46
Legal & General Group
United Kingdom
$26K -$96.4K -3,858 -77%
AIP
47
Ameritas Investment Partners
Nebraska
$20K +$22.2K +888 New
PA
48
Parallel Advisors
California
$15K
Bank of America
49
Bank of America
North Carolina
$14K +$15.6K +623 New
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$11K +$12.1K +484 New

PLRX Hedge Fund Activity: Q3 2020 in Review

55 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Pliant Therapeutics (PLRX) for Q3 2020, worth a combined $635M — down 28% from $877M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PLRX positions and 11 closed out — a net gain of 18 holders — while 7 added to existing stakes and 9 trimmed.

The largest buyer was Vanguard Group, adding an estimated $10.4M. The largest seller was Logos Global Management, cutting an estimated $7.99M.

  • 55 institutional investors held Pliant Therapeutics (PLRX) as of Q3 2020, up from 37 in Q2 2020.
  • Funds reported $635M of Pliant Therapeutics stock for Q3 2020, down 28% quarter-over-quarter.
  • 29 funds opened new Pliant Therapeutics positions in Q3 2020 and 11 closed out, a net change of +18 holders.
  • The largest Pliant Therapeutics buyer in Q3 2020 was Vanguard Group, an estimated $10.4M added.
  • The largest Pliant Therapeutics seller in Q3 2020 was Logos Global Management, an estimated $7.99M sold.

Based on aggregated 13F filings for Q3 2020.